6. You are the chief project manager for a small biotechnology company that has developed a new drug therapy. The patent on the drug will last for 16 years. You expect the drug will produce cash flows of $20 million for the first year, and that this amount will grow by 5% per year for the next 15 years. Once the patent expires, market competition from other biotech firms producing generic equivalents will drive all profits beyond year 15 to zero. How much should your firm be willing to invest in this project, assuming that the required rate of return is 17%